Back
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Vs. Belite Bio Industry Stock Comparison
Sell
19
CHAU
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF
Last Price:
15.27
Seasonality Move:
3.7%
Buy
89
BLTE
Belite Bio
Last Price:
67.75
Seasonality Move:
11.16%
Sell
19
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF (CHAU)
is a Sell
Is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF a Buy, Sell or Hold?
- The current Direxion Dly CSI 300 CHN A Shr Bl 2X ETF [CHAU] share price is $14.54. The Score for CHAU is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- CHAU is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
89
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy, Sell or Hold?
- The current Belite Bio [BLTE] share price is $64.02. The Score for BLTE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- BLTE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CHAU Stock Price Chart
What is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF's stock price today?
-
The Direxion Dly CSI 300 CHN A Shr Bl 2X ETF share price today is $14.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHAU is experiencing slight selling pressure.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $64.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLTE is experiencing selling pressure, which indicates risk of future bearish movement.
CHAU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 40.17 | Sell |
| Chaikin Money Flow: | -12054 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.3 - 16.92) | Sell |
| Bollinger Bands (100): | (11.8 - 17.46) | Sell |
BLTE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.52 | Buy |
| Relative Strength Index (14 RSI): | 36.22 | Sell |
| Chaikin Money Flow: | -100485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.51 - 82.53) | Sell |
| Bollinger Bands (100): | (44.23 - 67.87) | Buy |
CHAU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.31 | Sell |
| 20-day SMA: | 16.06 | Sell |
| 50-day SMA: | 16.6 | Sell |
| 200-day SMA: | 14.33 | Buy |
| 8-day EMA: | 15.25 | Sell |
| 20-day EMA: | 15.84 | Sell |
| 50-day EMA: | 15.83 | Sell |
| 200-day EMA: | 14.95 | Sell |
BLTE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.06 | Sell |
| 20-day SMA: | 76.97 | Sell |
| 50-day SMA: | 63.24 | Buy |
| 200-day SMA: | 49.93 | Buy |
| 8-day EMA: | 76.43 | Sell |
| 20-day EMA: | 75.29 | Sell |
| 50-day EMA: | 66.95 | Sell |
| 200-day EMA: | 52.3 | Buy |
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Earnings Growth & CHAU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Belite Bio Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||